Search hospitals > New York > Rochester
Highland Hospital
Claim this profileRochester, New York 14620
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Prostate Cancer
132 reported clinical trials
3 medical researchers
Summary
Highland Hospital is a medical facility located in Rochester, New York. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Prostate Cancer and other specialties. Highland Hospital is involved with conducting 132 clinical trials across 161 conditions. There are 3 research doctors associated with this hospital, such as Paul M. Barr, Yuhchyau Chen, and Richard G. Moore.Area of expertise
1Cancer
Global LeaderStage III
Stage II
Stage IV
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Paul M. BarrUniversity of Rochester5 years of reported clinical research
Expert in Cancer
Expert in Lymphoma
75 reported clinical trials
147 drugs studied
Yuhchyau ChenUniversity of Rochester2 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
36 reported clinical trials
79 drugs studied
Richard G. MooreUniversity of Rochester5 years of reported clinical research
Studies Cancer
Studies Adenocarcinoma
12 reported clinical trials
26 drugs studied
Clinical Trials running at Highland Hospital
Prostate Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Non-Small Cell Lung Cancer
Cancer
Laryngeal Cancer
Lung Cancer
Gallbladder Cancer
Breast Cancer
Lip and Oral Cavity Cancer
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Highland Hospital?
Highland Hospital is a medical facility located in Rochester, New York. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Prostate Cancer and other specialties. Highland Hospital is involved with conducting 132 clinical trials across 161 conditions. There are 3 research doctors associated with this hospital, such as Paul M. Barr, Yuhchyau Chen, and Richard G. Moore.